Bio-Rad Laboratories, Inc. (BIO) vs Hims & Hers Health, Inc. (HIMS)

A side-by-side comparison of Bio-Rad Laboratories, Inc. and Hims & Hers Health, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of September 10, 2026. Differences are shown without an overall score or investment verdict.

Compare

Total returnBIO vs HIMS

growth of $100 · dividends reinvested · last 7y
BIO +10.0% (+1.4%/yr)HIMS +180.0% (+15.8%/yr)HIMS compounded faster over this window
0200400600Start $100202120232025$110$280
BIO HIMS

BIO vs HIMS: by the numbers

  • BIO is the larger company ($9.94B vs $6.14B market cap).
  • BIO is profitable (8.59% net margin) while HIMS runs a net loss (-5.51%).
  • HIMS grew revenue faster over the past five years (67.47% vs 0.29% CAGR).

Metrics side by side

Valuation

MetricBIOHIMS
P/E ratio44.77N/A
Forward P/E38.31N/A
P/S ratio3.842.38
P/B ratio1.3918.94
EV / EBITDA27.78N/A
FCF yield3.55%1.46%

Profitability

MetricBIOHIMS
Gross margin51.90%73.84%
Operating margin9.08%4.50%
Net margin8.59%-5.51%
ROE3.10%-43.83%
ROIC1.54%-4.30%

Growth (annualized)

MetricBIOHIMS
Revenue CAGR (5Y)0.29%67.47%
EPS CAGR (5Y)-26.27%N/A
FCF CAGR (5Y)-9.65%N/A
Total return CAGR (5Y)-14.78%25.80%

Frequently asked

Which has grown faster, BIO or HIMS?
Over the past five years, HIMS grew revenue faster — BIO at a 0.29% CAGR versus HIMS at 67.47%.
Is BIO or HIMS more profitable?
BIO runs the higher net margin — BIO at 8.59% versus HIMS at -5.51%.
How have BIO and HIMS total returns compared?
Over the past 5 years, BIO delivered -14.78% and HIMS delivered 25.80% annualized total return. Past performance doesn't predict future results.

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified September 10, 2026.